Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             77 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ABC transporters in Leishmania and their role in drug resistance Ouellette, Marc
 1998
 33-35 1 p. 43-48
6 p.
 artikel
2 Activation and role of caspases in chemotherapy-induced apoptosis Schmitt, Estelle
 1999
 33-35 1 p. 21-29
9 p.
 artikel
3 Antifungal resistance in non- albicans Candida species Collin, Berjan
 1999
 33-35 1 p. 9-14
6 p.
 artikel
4 Antifungal susceptibility testing of yeasts: uses and limitations Reyes, Guadalupe
 2000
 33-35 1 p. 14-19
6 p.
 artikel
5 Antiviral drug resistance and helicase–primase inhibitors of herpes simplex virus Field, Hugh J.
 2011
 33-35 1 p. 45-51
7 p.
 artikel
6 Apoptosis induction by arsenic: mechanisms of action and possible clinical applications for treating therapy-resistant cancers Bode, Ann
 2000
 33-35 1 p. 21-29
9 p.
 artikel
7 Apoptosis pathways: turned on their heads? Fulda, Simone
 2003
 33-35 1 p. 1-3
3 p.
 artikel
8 Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase Götte, Matthias
 2000
 33-35 1 p. 30-38
9 p.
 artikel
9 Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma Nagane, Motoo
 1999
 33-35 1 p. 30-37
8 p.
 artikel
10 Creeping baselines and adaptive resistance to antibiotics Fernández, Lucía
 2011
 33-35 1 p. 1-21
21 p.
 artikel
11 Cryptosporidiosis and the challenges of chemotherapy Mead, Jan R.
 2002
 33-35 1 p. 47-57
11 p.
 artikel
12 Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) Bergman, Andries M
 2002
 33-35 1 p. 19-33
15 p.
 artikel
13 Drug transporters of platinum-based anticancer agents and their clinical significance Burger, Herman
 2011
 33-35 1 p. 22-34
13 p.
 artikel
14 3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm Elkins, Christopher A.
 2003
 33-35 1 p. 9-13
5 p.
 artikel
15 Editorial Georgopapadakou, Nafsika
 2002
 33-35 1 p. 1-
1 p.
 artikel
16 EDITORIAL Georgopapadakou, Nafsika
 2001
 33-35 1 p. 1-2
2 p.
 artikel
17 Editorial Georgopapadakou, Nafsika H.
 1998
 33-35 1 p. 1-
1 p.
 artikel
18 EDITORIAL Georgopapadakou, Nafsika H.
 1999
 33-35 1 p. 1-
1 p.
 artikel
19 Editorial 2000
 33-35 1 p. 1-
1 p.
 artikel
20 Editorial Board 2003
 33-35 1 p. i-
1 p.
 artikel
21 Editorial Board 1998
 33-35 1 p. i-
1 p.
 artikel
22 Editorial Board 2004
 33-35 1 p. i-
1 p.
 artikel
23 Editorial Board 2011
 33-35 1 p. i-
1 p.
 artikel
24 Editorial for Vol. 6, Issue 1 Georgopapadakou, Nafsika
 2003
 33-35 1 p. v-
1 p.
 artikel
25 EGF receptor targeting in therapy-resistant human tumors Schmidt, Mathias
 2002
 33-35 1 p. 11-18
8 p.
 artikel
26 Eighth conference on DNA topoisomerases and therapy Amsterdam, The Netherlands 15–17 October 1997 Giaccone, Giuseppe
 1998
 33-35 1 p. 73-75
3 p.
 artikel
27 Emerging new therapies for chemotherapy—resistant cancer using adenoviral vectors Nemunaitis, John
 2002
 33-35 1 p. 34-46
13 p.
 artikel
28 Enhanced oncolytic potency of replicative adenovirus expressing p53 Nemunaitis, John
 2003
 33-35 1 p. 5-7
3 p.
 artikel
29 Erratum 2000
 33-35 1 p. 66-
1 p.
 artikel
30 Factors determining cellular mechanisms of resistance to antimitotic drugs Cabral, Fernando
 2001
 33-35 1 p. 3-8
6 p.
 artikel
31 Glycolysis as a target for the design of new anti-trypanosome drugs Verlinde, Christophe L.M.J.
 2001
 33-35 1 p. 50-65
16 p.
 artikel
32 High-dose chemotherapy: how resistant is breast cancer? Pusztai, Lajos
 1998
 33-35 1 p. 62-72
11 p.
 artikel
33 Hypoxic cytotoxic agents: a new approach to cancer chemotherapy Brown, J.Martin
 2000
 33-35 1 p. 7-13
7 p.
 artikel
34 Immunotherapy for invasive fungal infections: from bench to bedside Pappas, Peter G.
 2004
 33-35 1 p. 3-10
8 p.
 artikel
35 Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC Ito, Teruyo
 2003
 33-35 1 p. 41-52
12 p.
 artikel
36 Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer Olmos, Yolanda
 2011
 33-35 1 p. 35-44
10 p.
 artikel
37 Lethal mutagens: broad-spectrum antivirals with limited potential for development of resistance? Freistadt, Marion S.
 2004
 33-35 1 p. 19-24
6 p.
 artikel
38 Literature Highlights: recent research in infectious disease drug resistance 2004
 33-35 1 p. 69-73
5 p.
 artikel
39 Macrolide resistance Weisblum, Bernard
 1998
 33-35 1 p. 29-41
13 p.
 artikel
40 Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity Arts, Eric J.
 1998
 33-35 1 p. 21-28
8 p.
 artikel
41 Mechanisms of fluoroquinolone resistance Hooper, David C.
 1999
 33-35 1 p. 38-55
18 p.
 artikel
42 Mechanisms of resistance imatinib (STI571) in preclinical models and in leukemia patients Weisberg, Ellen
 2001
 33-35 1 p. 22-28
7 p.
 artikel
43 Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agents Krystal, Geoffrey W.
 2001
 33-35 1 p. 16-21
6 p.
 artikel
44 meetings Calendar 2002
 33-35 1 p. 58-60
3 p.
 artikel
45 MEETINGS CALENDAR 2001
 33-35 1 p. 75-77
3 p.
 artikel
46 Meetings calendar 1998
 33-35 1 p. 79-80
2 p.
 artikel
47 Meetings Calendar 1999
 33-35 1 p. 73-77
5 p.
 artikel
48 Meetings Calendar 2000
 33-35 1 p. 59-65
7 p.
 artikel
49 Membrane and cell wall targets in Aspergillus fumigatus Beauvais, Anne
 2001
 33-35 1 p. 38-49
12 p.
 artikel
50 Mobile elements in the evolution and spread of multiple-drug resistance in staphylococci Firth, Neville
 1998
 33-35 1 p. 49-58
10 p.
 artikel
51 Mother-to-child transmission of drug-resistant HIV Kijak, Gustavo H.
 2001
 33-35 1 p. 29-37
9 p.
 artikel
52 New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort Hoffman, Aviad
 2011
 33-35 1 p. 52-66
15 p.
 artikel
53 NF-κB in cancer—a friend turned foe Ravi, Rajani
 2004
 33-35 1 p. 53-67
15 p.
 artikel
54 [No title] Georgopapadakou, Nafsika
 2004
 33-35 1 p. 1-
1 p.
 artikel
55 Opportunistic amoebae: challenges in prophylaxis and treatment Schuster, Frederick L.
 2004
 33-35 1 p. 41-51
11 p.
 artikel
56 pH and drug resistance in tumors Raghunand, Natarajan
 2000
 33-35 1 p. 39-47
9 p.
 artikel
57 Pneumocystis carinii: a fungus resistant to antifungal therapies — mechanisms of action of antipneumocystis drugs Russian, David A.
 1998
 33-35 1 p. 16-20
5 p.
 artikel
58 Preventing antimalarial drug resistance through combinations White, N.J.
 1998
 33-35 1 p. 3-9
7 p.
 artikel
59 Proposed alternatives for the use of anti-HIV drugs Berkhout, Benjamin
 1999
 33-35 1 p. 69-70
2 p.
 artikel
60 Proposed alternatives for the use of anti-HIV drugs: is it appropriate? Coffin, John M.
 1999
 33-35 1 p. 71-72
2 p.
 artikel
61 3rd International Conference on Therapies for Viral Hepatitis King, Robert W.
 2000
 33-35 1 p. 55-57
3 p.
 artikel
62 Recent progress in the diagnosis of fungal infections in the immunocompromised host Erjavec, Z
 2002
 33-35 1 p. 3-10
8 p.
 artikel
63 Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase Bacheler, Lee T.
 1999
 33-35 1 p. 56-67
12 p.
 artikel
64 Role of angiogenesis in the response to anticancer therapies Teicher, Beverly A.
 1998
 33-35 1 p. 59-61
3 p.
 artikel
65 Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? Odds, Frank C.
 1998
 33-35 1 p. 11-15
5 p.
 artikel
66 Subcellular targeting regulates the function of caspase-activated protein kinases in apoptosis Jakobi, Rolf
 2004
 33-35 1 p. 11-17
7 p.
 artikel
67 Targeting hypoxia tolerance in cancer Wouters, Bradly G
 2004
 33-35 1 p. 25-40
16 p.
 artikel
68 Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential Olie, Robet.A.
 2001
 33-35 1 p. 9-15
7 p.
 artikel
69 Telomerase as a potential anticancer target: growth inhibition and genomic instability Faraoni, Isabella
 2000
 33-35 1 p. 3-6
4 p.
 artikel
70 The ABC transporter genes of Plasmodium falciparum and drug resistance Peel, Sheila A.
 2001
 33-35 1 p. 66-74
9 p.
 artikel
71 The IGF/IGF-1 receptor signaling pathway as a potential target for cancer therapy Burtscher, Ingo
 1999
 33-35 1 p. 3-8
6 p.
 artikel
72 The mechanism of resistance to sulfa drugs in Plasmodium falciparum Triglia, Tony
 1999
 33-35 1 p. 15-19
5 p.
 artikel
73 The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer Gerweck, Leo E.
 2000
 33-35 1 p. 49-50
2 p.
 artikel
74 The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy Grant, Steven
 2003
 33-35 1 p. 15-26
12 p.
 artikel
75 37th interscience conference on antimicrobial agents and chemotherapy (ICAAC) Toronto, Canada, 28 September–1 October 1997 Georgopapadakou, Nafsika H.
 1998
 33-35 1 p. 76-77
2 p.
 artikel
76 Tumor p53 status and response to topoisomerase II inhibitors Valkov, Nikola I.
 2003
 33-35 1 p. 27-39
13 p.
 artikel
77 Workshop on ABC Transporters and Human Diseases Ambudkar, Suresh V.
 2000
 33-35 1 p. 51-54
4 p.
 artikel
                             77 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland